4/A
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-18-046262
Options or other derivatives
- Chief Scientific Officer acquired 4,137 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Biller Scott Chief Scientific Officer | 2018-03-28 | Option exercise · Stock option (right to buy) | −37 | 1,766 | D | ||
| Biller Scott Chief Scientific Officer | 2018-03-28 | Option exercise · Stock option (right to buy) | −4,100 | 27,718 | D | ||
Loading xslF345X03/doc4a.xml…